Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10191207rdf:typepubmed:Citationlld:pubmed
pubmed-article:10191207lifeskim:mentionsumls-concept:C0019351lld:lifeskim
pubmed-article:10191207lifeskim:mentionsumls-concept:C0019342lld:lifeskim
pubmed-article:10191207lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:10191207lifeskim:mentionsumls-concept:C0024518lld:lifeskim
pubmed-article:10191207lifeskim:mentionsumls-concept:C0231220lld:lifeskim
pubmed-article:10191207lifeskim:mentionsumls-concept:C0598513lld:lifeskim
pubmed-article:10191207lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:10191207lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:10191207lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:10191207pubmed:issue5lld:pubmed
pubmed-article:10191207pubmed:dateCreated1999-6-7lld:pubmed
pubmed-article:10191207pubmed:abstractTextThe clinical spectrum of herpes simplex virus (HSV) infections, ranging from asymptomatic to frequently distressing outbreaks, suggests that there may be immunologic determinants of disease severity that are associated with human leukocyte antigen (HLA) expression. A controlled, prospective study identified several major histocompatibility complex (MHC) class I and II antigens whose frequencies are associated with HSV-2 infection or with frequent symptomatic genital recurrences. Previous studies were hampered by the inability to serologically identify patients with asymptomatic HSV-2 infection. Clinical evaluation and Western blot assay were used to identify 3 subject cohorts: 1 with no prior HSV infections, 1 with HSV-2 antibodies but no recognized symptoms, and 1 with HSV-2 antibodies and frequent genital recurrences. Statistical comparisons of HLA frequencies among these cohorts showed associations of HLA-B27 and -Cw2 with symptomatic disease. Also, HLA-Cw4 was significantly associated with HSV-2 infection. These associations indicate that immunologic factors linked to the MHC influence the risk of HSV-2 infection and disease expression.lld:pubmed
pubmed-article:10191207pubmed:languageenglld:pubmed
pubmed-article:10191207pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10191207pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10191207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10191207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10191207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10191207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10191207pubmed:statusMEDLINElld:pubmed
pubmed-article:10191207pubmed:monthMaylld:pubmed
pubmed-article:10191207pubmed:issn0022-1899lld:pubmed
pubmed-article:10191207pubmed:authorpubmed-author:CoreyLLlld:pubmed
pubmed-article:10191207pubmed:authorpubmed-author:WaldAAlld:pubmed
pubmed-article:10191207pubmed:authorpubmed-author:StrausS ESElld:pubmed
pubmed-article:10191207pubmed:authorpubmed-author:NamJ MJMlld:pubmed
pubmed-article:10191207pubmed:authorpubmed-author:WarrenTTlld:pubmed
pubmed-article:10191207pubmed:authorpubmed-author:SimonisTTlld:pubmed
pubmed-article:10191207pubmed:authorpubmed-author:Lekstrom-Hime...lld:pubmed
pubmed-article:10191207pubmed:authorpubmed-author:HohmanPPlld:pubmed
pubmed-article:10191207pubmed:issnTypePrintlld:pubmed
pubmed-article:10191207pubmed:volume179lld:pubmed
pubmed-article:10191207pubmed:ownerNLMlld:pubmed
pubmed-article:10191207pubmed:authorsCompleteYlld:pubmed
pubmed-article:10191207pubmed:pagination1077-85lld:pubmed
pubmed-article:10191207pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:10191207pubmed:meshHeadingpubmed-meshheading:10191207...lld:pubmed
pubmed-article:10191207pubmed:meshHeadingpubmed-meshheading:10191207...lld:pubmed
pubmed-article:10191207pubmed:meshHeadingpubmed-meshheading:10191207...lld:pubmed
pubmed-article:10191207pubmed:meshHeadingpubmed-meshheading:10191207...lld:pubmed
pubmed-article:10191207pubmed:meshHeadingpubmed-meshheading:10191207...lld:pubmed
pubmed-article:10191207pubmed:meshHeadingpubmed-meshheading:10191207...lld:pubmed
pubmed-article:10191207pubmed:meshHeadingpubmed-meshheading:10191207...lld:pubmed
pubmed-article:10191207pubmed:meshHeadingpubmed-meshheading:10191207...lld:pubmed
pubmed-article:10191207pubmed:meshHeadingpubmed-meshheading:10191207...lld:pubmed
pubmed-article:10191207pubmed:meshHeadingpubmed-meshheading:10191207...lld:pubmed
pubmed-article:10191207pubmed:meshHeadingpubmed-meshheading:10191207...lld:pubmed
pubmed-article:10191207pubmed:meshHeadingpubmed-meshheading:10191207...lld:pubmed
pubmed-article:10191207pubmed:meshHeadingpubmed-meshheading:10191207...lld:pubmed
pubmed-article:10191207pubmed:meshHeadingpubmed-meshheading:10191207...lld:pubmed
pubmed-article:10191207pubmed:meshHeadingpubmed-meshheading:10191207...lld:pubmed
pubmed-article:10191207pubmed:meshHeadingpubmed-meshheading:10191207...lld:pubmed
pubmed-article:10191207pubmed:meshHeadingpubmed-meshheading:10191207...lld:pubmed
pubmed-article:10191207pubmed:year1999lld:pubmed
pubmed-article:10191207pubmed:articleTitleAssociation of major histocompatibility complex determinants with the development of symptomatic and asymptomatic genital herpes simplex virus type 2 infections.lld:pubmed
pubmed-article:10191207pubmed:affiliationMedical Virology Section, Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. juliel@nhgri.nih.govlld:pubmed
pubmed-article:10191207pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10191207lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10191207lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10191207lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10191207lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10191207lld:pubmed